REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNatwest Regulatory News (NWG)

Share Price Information for Natwest (NWG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 317.00
Bid: 274.00
Ask: 320.00
Change: 0.00 (0.00%)
Spread: 46.00 (16.788%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 317.00
NWG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Off-Market Purchase of Ordinary Shares from HMT

22 May 2023 07:00

RNS Number : 1678A
NatWest Group plc
22 May 2023
 

NatWest Group plc

22 May 2023

Off-market purchase of 469,200,081 ordinary shares from His Majesty's Treasury ("HM Treasury")

NatWest Group plc (the "Company") has agreed with HM Treasury to make an off-market purchase (the "Off-Market Purchase") of 469,200,081 ordinary shares in the Company with a nominal value of £1.0769* each ("Ordinary Shares") at a price of 268.4 pence per Ordinary Share, being the closing price of the Ordinary Shares on the London Stock Exchange on 19 May 2023. The total consideration for the Off-Market Purchase will be £1,259,333,017.40.

The purchased Ordinary Shares represent 4.95 per cent of the Company's issued Ordinary Share capital (excluding treasury shares). The Off-Market Purchase is expected to settle on 24 May 2023.

A contract (the "Directed Buyback Contract") between the Company and HM Treasury was approved by the shareholders of the Company at a General Meeting held on 6 February 2019 and signed on 7 February 2019. Amendments to the Directed Buyback Contract were approved by the shareholders of the Company at a General Meeting held on 25 August 2022 and signed on 17 November 2022. The authority from shareholders to make off-market purchases of Ordinary Shares from HM Treasury (or its nominee) under the terms of the Directed Buyback Contract was renewed at the Annual General Meeting on 25 April 2023.

 

The Company intends to cancel 336,200,081 of the purchased Ordinary Shares and hold the remaining 133,000,000 Ordinary Shares in treasury. Holding Ordinary Shares as treasury shares gives the Company the ability to cancel or re-issue such Ordinary Shares at a later date, quickly and cost effectively, and may provide the Company with additional flexibility in the management of its capital base, including the allotment of Ordinary Shares in relation to its employee share plans.

Under Chapter 11 of the Listing Rules, the Directed Buyback Contract constitutes a related party transaction. However, the Off-Market Purchase is treated as a smaller related party transaction under LR 11.1.10 R.

Upon settlement of the above transaction:

 

- the Company will hold 217,559,121 of its Ordinary Shares as treasury shares;

- the Company will have in issue 9,008,272,152 Ordinary Shares (excluding treasury shares)** and 483,140 Cumulative Preference Shares of £1; and

- HM Treasury will hold approximately 38.69 per cent. of the Company's voting rights.

 

The above transaction would have reduced the Company's CET1 ratio of 14.4 per cent at 31 March 2023 by 71 basis points.  TNAV per share as at 31 March 2023 was 278p, pro-forma TNAV per share including the payment of the 2022 final dividend of 10p would be 268p and the proposed DBB transaction would be TNAV per share neutral.

The person responsible for arranging the release of this announcement on behalf of the Company is Alexander Holcroft, Head of Investor Relations.

\* The nominal value of Ordinary Shares without rounding is £1.076923076923077 per share

**This number does not take into account any purchases of Ordinary Shares which (i) may have taken place but have not, at the date of this announcement, settled under the Company's On Market Share Buyback Programme which commenced on 20 February 2023 (the "Programme") or (ii) may take place under the Programme between the date of this announcement and settlement of the Off-Market Purchase.

 

 

 

 

 

 

 

 

Further information:

 

Investor Relations

+ 44 (0)207 672 1758

 

Media Relations

+44 (0)131 523 4205

 

Legal Entity Identifier: 2138005O9XJIJN4JPN90 

 

Forward-looking statements

This document may include forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, such as statements that include, without limitation, the words 'expect', 'estimate', 'project', 'anticipate', 'commit', 'believe', 'should', 'intend', 'will', 'plan', 'could', 'probability', 'risk', 'Value-at-Risk (VaR)', 'target', 'goal', 'objective', 'may', 'endeavour', 'outlook', 'optimistic', 'prospects' and similar expressions or variations on these expressions. These statements concern or may affect future matters, such as the Company's future economic results, business plans and strategies.  In particular, this document may include forward-looking statements relating to the Company in respect of, but not limited to: its economic and political risks, its regulatory capital position and related requirements, its financial position, profitability and financial performance (including financial, capital, cost savings and operational targets), the implementation of its purpose-led strategy, its environmental, social and governance and climate related targets, its access to adequate sources of liquidity and funding, increasing competition from new incumbents and disruptive technologies, its exposure to third party risks, its ongoing compliance with the UK ring-fencing regime and ensuring operational continuity in resolution, its impairment losses and credit exposures under certain specified scenarios, substantial regulation and oversight, ongoing legal, regulatory and governmental actions and investigations, the transition of LIBOR and IBOR rates to replacement risk free rates and the Company's exposure to operational risk, conduct risk, cyber, data and IT risk, financial crime risk, key person risk and credit rating risk. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, future growth initiatives (including acquisitions, joint ventures and strategic partnerships), the outcome of legal, regulatory and governmental actions and investigations, the level and extent of future impairments and write-downs, legislative, political, fiscal and regulatory developments, accounting standards, competitive conditions, technological developments, interest and exchange rate fluctuations, general economic and political conditions and the impact of climate-related risks and the transitioning to a net zero economy. These and other factors, risks and uncertainties that may impact any forward-looking statement or the Company's actual results are discussed in the Company's UK 2022 Annual Report and Accounts (ARA), the Company's Interim Management Statement for Q1 2023 and its other public filings. The forward-looking statements contained in this document speak only as of the date of this document and the Company does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCELLBLXELEBBV
Date   Source Headline
23rd Nov 20224:08 pmRNSDividend Declaration
11th Nov 20227:00 amRNSQ3 2022 Pillar 3 Supplements
10th Nov 20223:53 pmRNSDirector/PDMR Shareholding
8th Nov 20224:55 pmRNSHolding(s) in Company
7th Nov 20227:30 amRNSUlster Bank Retail Business: Acquisition Completed
4th Nov 202211:19 amRNSPricing of USD 7.472% Senior Callable Notes
31st Oct 20223:35 pmRNSTotal Voting Rights
28th Oct 20225:52 pmRNSPublication of Suppl.Prospcts
28th Oct 20227:00 amRNSNWG Q3 IMS Interim Management Statement 2022
20th Oct 20229:00 amRNSNatWest and Vodeno Create Strategic Partnership
5th Oct 20221:51 pmRNSBlock listing six monthly return
30th Sep 20222:15 pmRNSDirectorate Change
30th Sep 202212:45 pmRNSTotal Voting Rights
26th Sep 20225:44 pmRNSPublication of Suppl.Prospcts
26th Sep 20223:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20225:25 pmRNSChanges to our Board
23rd Sep 202212:30 pmRNSNatWest Group notes rating actions by Moody's
20th Sep 20229:30 amRNSTR-1: Notification of Major Holdings
20th Sep 20228:00 amRNSBank of America Annual Financials CEO Conference
13th Sep 20228:30 amRNSBarclays Global Financial Services Conference
8th Sep 20222:00 pmRNSDirector/PDMR Shareholding
5th Sep 202211:18 amRNSAdam & Company Private Banking Business
2nd Sep 20222:43 pmRNSPublication of Final Terms - Replacement
2nd Sep 20221:44 pmRNSPublication of Final Terms
31st Aug 20226:23 pmRNSAdjustment to conversion prices for NWG's AT1s
31st Aug 20222:34 pmRNSTotal Voting Rights
30th Aug 20228:10 amRNSShare consolidation and total voting rights
25th Aug 20224:32 pmRNSResult of General Meeting and Class Meeting
25th Aug 20222:00 pmRNSGeneral Meeting and Class Meeting Statement
12th Aug 20222:23 pmRNSUpdate to Financial Impact of Tender Offers
12th Aug 20227:00 amRNSH1 2022 Pillar 3 Supplements
11th Aug 202210:15 amRNSHolding(s) in Company
10th Aug 20226:18 pmRNSFinancial Impact of Tender Offers
10th Aug 20224:30 pmRNSDirector/PDMR Shareholding
9th Aug 20226:26 pmRNSResults of Tender Offers
9th Aug 202211:08 amRNSPricing of Tender Offers
9th Aug 20227:00 amRNSNotice of General Meeting and Class Meeting
1st Aug 20225:02 pmRNSTender Offer
1st Aug 20224:32 pmRNSPublication of Final Terms
29th Jul 20224:59 pmRNSPublication of Supplementary Prospectus
29th Jul 20223:19 pmRNSTotal Voting Rights
29th Jul 20227:00 amRNSInterim Results - NatWest Markets N.V.
29th Jul 20227:00 amRNSInterim Results - NatWest Group (Part 2 of 2)
29th Jul 20227:00 amRNSInterim Results - NatWest Group (Part 1 of 2)
22nd Jul 20228:01 amRNSCompetition clearance received on Ulster Bank deal
15th Jul 20226:05 pmRNSTransaction in Own Shares
14th Jul 20225:21 pmRNSTransaction in Own Shares
13th Jul 20225:15 pmRNSTransaction in Own Shares
12th Jul 20225:14 pmRNSTransaction in Own Shares
11th Jul 20225:21 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.